CURE’s metastatic breast cancer page features the latest cancer news and updates on metastatic breast cancer Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in metastatic breast cancer.
April 16th 2025
Bria-IMT plus check point inhibitors had a median overall survival which outperformed that of antibody-drug conjugates in HR+ metastatic breast cancer.
A Pioneer of Metastatic Breast Cancer Research Who Never Gives up on Patients
February 17th 2022A surgical oncologist honors an admirable doctor in the field who refuses to falter in the face of challenges in order to do exhaust every opportunity possible to improve the lives of patients with metastatic breast cancer.
A Helpline for Patients With Breast Cancer in Relentless Pursuit of Patient Support
February 6th 2022After receiving a breast cancer diagnosis at age 43, one woman became involved in advocacy with SHARE Cancer Support, spending hours speaking to women on the phone about treatments, emotional impacts and personal issues related to their breast cancer.
I Didn’t Think I Would Be Strong Enough to Survive Cancer 20 Years Ago, But I Was so Wrong
February 1st 2022A woman with metastatic breast cancer reflects on her pre-cancer life 20 years ago and how her perspective on the disease has shifted as she’s reached a level of acceptance and hope for the future.
A Tireless Champion for Change in the Metastatic Breast Cancer Field
February 1st 2022A colleague describes how a woman who was diagnosed with breast cancer that later metastasized felt a lack of support and research, leading her to launch support programs for other patients and step into the advocacy field.
Understanding the Importance of NCCN Guidelines in Metastatic TNBC
December 15th 2021As part of its Speaking Out video series, CURE spoke with Dr. Rebecca Moroose, from Orlando Health Cancer Institute, and Dr. Virginia G. Kaklamani, from UT Health San Antonio, about the National Comprehensive Cancer Network guidelines and what they mean for patients.